This suggests that GLP-1 receptor agonists may confer cardiovascular protection through multiple mechanisms, potentially including anti-inflammatory effects, blood pressure reduction, and vascular benefits, in addition to lipid improvements
"Human-specific induction of glutathione peroxidase-3 by proteasome inhibition in cardiovascular cells"
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist (type 2 diabetes Phase 2 trial)
Molecular Profile (CAS 170851-70-4) Storage, Handling, and Reconstitution of the Ipamorelin Peptide Store the lyophilized vial at -20 C (-4 F), sealed and protected from light and moisture
Sadly, this happened as a combination of too hot of a heat tool and then sun damage